by Dan Millar | Sep 20, 2018 | Abstract Preview
Similar to the previous blog post covering the AABB abstracts from the Vancouver General Hospital study, this post will cover an abstract generated by a hospital that has recently evaluated ThromboLUX. This time we are looking at the work done by Dr. Inga Gurrevich,... by Dan Millar | Sep 13, 2018 | Abstract Preview
Over the next four weeks, this blog will be previewing upcoming AABB 2018 abstracts that feature ThromboLUX. This post covers two abstracts that came out of one study. The data set generated during a randomized controlled trial conducted at Vancouver General Hospital... by Dr. Elisabeth Maurer-Spurej | Aug 28, 2018 | Literature Review
This page is Part 2 of a two-part blog post on the impact of ABO matching for platelet transfusion. Part 1 provides provide an overview of the ABO system as it applies to platelets, definitions of ABO platelet matching terminology, and common endpoints for studies... by Dr. Elisabeth Maurer-Spurej | Aug 27, 2018 | Literature Review
There has been an ongoing debate over the importance of ABO matching for platelet transfusions for well over 50 years. A survey from 2007 showed that 17% of North American institutions did not have a formal ABO policy and 50% of the institutions with a policy gave ABO... by Dan Millar | Jul 31, 2018 | Data Summary
This month marks a special moment for ThromboLUX. There have now been over 10,000 ThromboLUX tests conducted in the US. To be exact, there have been 10,522 tests performed at the time of writing. This means 10,522 opportunities to better understand platelet... by Dr. Elisabeth Maurer-Spurej | Jul 18, 2018 | Literature Review
On this blog we have discussed the rates of activation among hospital blood banks and platelet suppliers, we have given an overview on the sources of platelet activation, and the impact transfusions of activated platelets have on platelet utilization. However, the... by Dan Millar | Jun 29, 2018 | Data Summary
On this blog, we have discussed the many possible causes of platelet activation. One factor often under scrutiny is the impact platelet age has on activation status. At LightIntegra we have collected a large database of platelet activation status from platelet units... by Dan Millar | Jun 11, 2018 | Data Summary
We have found that hospitals with a higher percentage of activated platelets in their inventory use more platelets per patient. Platelet activation is a normal part of the platelet life cycle and platelets can become activated from a wide variety of sources. Some of... by Dan Millar | May 3, 2018 | Abstract Preview, Data Summary
A registered clinical study investigating the effect of platelet activation status on transfusion outcomes was conducted at Vancouver General Hospital (VGH) from 2011 to 2014 under the guidance of Dr. Kate Chipperfield. This study enrolled 200 hematology-oncology... by Dr. Elisabeth Maurer-Spurej | Apr 18, 2018 | Literature Review
Anyone who works with platelets knows they are extremely sensitive cells that are activated in many ways. This sensitive nature is an integral part of platelet function. We regularly receive questions about the impact of post-donation processes like gamma irradiation,... 